✦ LIBER ✦

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

✍ Scribed by Daniel J Drucker; Michael A Nauck

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incretin-based treatment of type 2 diabe

✍ Carolyn F. Deacon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Novel therapeutics for type 2 diabetes:

✍ E.J. Verspohl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 913 KB

Incretin-based Therapies (Glucagon-like

✍ Amir Hanna; Vincent Woo; Jean-François Yale; Elaine M. Cooke 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 208 KB

Dipeptidyl Peptidase IV Inhibitors and t

✍ Alissa K. Langley; Terri J. Suffoletta; Heath R. Jennings 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Glucagon-like peptide 1 and inhibitors o

✍ Jens Juul Holst; Carolyn F Deacon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Treatment of type 2 diabetes with glucag

✍ K. B. Hansen; F. K. Knop; J. J. Holst; T. Vilsbøll 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB